Anest. intenziv. Med. 2005;16(1):57-64

Metabolismus, endokrinologie a výživa - novinky 2004Intensive Care Medicine

M. Matějovič1, F. Novák2, A. Kroužecký1, J. Raděj1, I. Novák1
1 JIP, I. interní klinika Univerzity Karlovy v Praze, Lékařské fakulty a Fakultní nemocnice, Plzeň
2 JIP, IV. interní klinika Univerzity Karlovy v Praze, 1. lékařské fakulty a Všeobecné fakultní nemocnice, Praha

Studie, zkoumající změny buněčného energetického metabolismu u kriticky nemocných, přinášejí novou alternativní hypotézu, která vysvětluje příčinu multiorgánové dysfunkce.

Published: February 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Matějovič M, Novák F, Kroužecký A, Raděj J, Novák I. Metabolismus, endokrinologie a výživa - novinky 2004. Anest. intenziv. Med. 2005;16(1):57-64.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Brealey, D., Brand, M., Hargreaves, I. et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet, 2002, 360, p. 219-23. Go to original source... Go to PubMed...
    2. Brealey, D., Karyampudi, S., Jacques, T. S. et al. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2004, 286, R491-R497. Go to original source... Go to PubMed...
    3. Singer, M., De Santis, V., Vitale, D., Jeffcoate, W. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet, 2004, 364, p. 545-548. Go to original source... Go to PubMed...
    4. Watts, J. A., Kline, J. A., Thornton, L. R., Grattan, R. M., Brar, S. S. Metabolic dysfunction and depletion of mitochondria in hearts of septic rats. J. Mol. Cell. Cardiol., 2004, 36, p. 141-150. Go to original source... Go to PubMed...
    5. van den Berghe, G., Wouters, P., Weekers, F. et al. Intensive insulin therapy in the critically ill patients. N. Engl. J. Med., 2001, 345, p. 1359-1367. Go to original source... Go to PubMed...
    6. Krinsley, J. S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin. Proc., 2004, 79, p. 992-1000. Go to original source... Go to PubMed...
    7. Van den Berghe, G., Wouters, P. J., Bouillon, R. et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit. Care Med., 2003, 31, p. 359-366. Go to original source... Go to PubMed...
    8. Finney, S. J., Zekveld, C., Elia, A., Evans, T. W. Glucose control and mortality in critically ill patients. JAMA, 2003, 290, p. 2041-2047. Go to original source... Go to PubMed...
    9. Wasmuth, H. E., Kunz, D., Graf, J. et al. Hyperglycemia at admission to the intensive care unit is associated with elevated serum concentrations of interleukin-6 and reduced ex vivo secretion of tumor necrosis factor-alpha. Crit. Care Med., 2004, 32, p. 1109-1114. Go to original source... Go to PubMed...
    10. Hansen, T. K., Thiel, S., Wouters, P. J., Christistiansen, J. S., Van den Berghe, G. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J. Clin. Endocrinol. Metab., 2003, 88, p. 1082-1088. Go to original source... Go to PubMed...
    11. Weekers, F., Michalaki, M., Coopmans, W. et al. Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone, and insulin infusion in a rabbit model of prolonged critical illness. Endocrinology, 2004, 145, p. 205-213. Go to original source... Go to PubMed...
    12. Marik, P. E., Raghavan, M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med., 2004, 30, p. 748-756. Go to original source... Go to PubMed...
    13. Leverve, X. Hyperglycemia and oxidative stress: complex relationships with attractive prospects. Intensive Care Med., 2003, 29, p. 511-514. Go to original source... Go to PubMed...
    14. Bonville, D. A., Parker, T. S., Levine, D. M. et al. The relationships of hypocholesterolemia to cytokine concentrations and mortality in critically ill patients with systemic inflammatory response syndrome. Surg. Infect. (Larchmt)., 2004, 5, p. 39-49. Go to original source... Go to PubMed...
    15. van Leeuwen, H. J., Heezius, E. C., Dallinga, G. M., van Strijp, J. A., Verhoef, J., van Kessel, K. P. Lipoprotein metabolism in patients with severe sepsis. Crit. Care Med., 2003, 31, p. 1359-1366. Go to original source... Go to PubMed...
    16. Chenaud, C., Merlani, P. G., Roux-Lombard, P. et al. Low apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation. Crit. Care Med., 2004, 32, p. 632-637. Go to original source... Go to PubMed...
    17. Mesotten, D., Swinnen, J. V., Vanderhoydonc, F., Wouters, P. J., Van den Berghe, G. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J. Clin. Endocrinol. Metab., 2004, 89, p. 219-226. Go to original source... Go to PubMed...
    18. Wu, A., Hinds, C. J., Thiemermann, C. High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock, 2004, 21, p. 210-221. Go to original source... Go to PubMed...
    19. McDonald, M. C., Dhadly, P., Cockerill, G. W. et al. Reconstituted high-density lipoprotein attenuates organ injury and adhesion molecule expression in a rodent model of endotoxic shock. Shock, 2003, 20, p. 551-557. Go to original source... Go to PubMed...
    20. Cuzzocrea, S., Dugo, L., Patel, N. S. et al. High-density lipoproteins reduce the intestinal damage associated with ischemia/reperfusion and colitis. Shock, 2004, 21, p. 342-351. Go to original source... Go to PubMed...
    21. Nissen, S. E., Tsunoda, T., Tuzcu, E. M. et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA, 2003, 290, p. 2292-2300. Go to original source... Go to PubMed...
    22. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Cochrane Injuries Group Albumin Reviewers. BMJ, 1998, 317, p. 235-240.
    23. Finfer, S., Bellomo, R., Boyce, N., French, J., Myburgh, J., Norton, R.; SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N. Engl. J. Med., 2004, 350, p. 2247-2256. Go to original source...
    24. Quinlan, G. J., Mumby, S., Martin, G. S., Bernard, G. R., Gutteridge, J. M., Evans, T. W. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit. Care Med., 2004, 32, p. 755-759. Go to original source... Go to PubMed...
    25. Morgan, T. J., Venkatesh, B., Hall, J. Crystalloid strong ion difference determines metabolic acid-base change during acute normovolaemic haemodilution. Intensive Care Med., 2004, 30, p. 1432-1437. Go to original source... Go to PubMed...
    26. Kellum, J. A. Saline-induced hyperchloremic metabolic acidosis. Crit Care Med., 2002, 30, p. 259-261. Go to original source... Go to PubMed...
    27. Kellum, J. A., Song, M., Venkataraman, R. Effects of hyperchloremic acidosis on arterial pressure and circulating inflammatory molecules in experimental sepsis. Chest, 2004, 125, p. 243-248. Go to original source... Go to PubMed...
    28. Van den Berghe, G. Endocrine evaluation of patients with critical illness. Endocrinol. Metab. Clin. North. Am., 2003, 32, p. 385-410. Go to original source... Go to PubMed...
    29. Takala, J., Ruokonen, E., Webster, N. R., Nielsen, M.S. et al. Increased mortality associated with growth hormone treatment in critically ill adults. N. Engl. J. Med., 1999, 341, p. 785-792. Go to original source... Go to PubMed...
    30. Peeters, R. P., Wouters, P. J., Kaptein, E., van Toor, H., Visser, T. J., Van den Berghe, G. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J. Clin. Endocrinol. Metab., 2003, 88, p. 3202-3211. Go to original source... Go to PubMed...
    31. Weekers, F., Michalaki, M., Coopmans, W. et al. Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone, and insulin infusion in a rabbit model of prolonged critical illness. Endocrinology, 2004, 145, p. 205-213. Go to original source... Go to PubMed...
    32. Schilling, T., Grundling, M., Strang, C. M., Moritz, K. U., Siegmund, W., Hachenberg, T. Effects of dopexamine, dobutamine or dopamine on prolactin and thyreotropin serum concentrations in high-risk surgical patients. Intensive Care Med., 2004, 30, p. 1127-1133. Go to original source... Go to PubMed...
    33. Dhatariya, K. K. Is there a role for dehydroepiandrosterone replacement in the intensive care population? Intensive Care Med., 2003, 29, p. 1877-1880. Go to original source... Go to PubMed...
    34. Chaudry, I. H., Samy, T. S., Schwacha, M. G. et al. Endocrine targets in experimental shock. J. Trauma, 2003, 54, 5, Suppl, S118-S125. Go to original source... Go to PubMed...
    35. Oberbeck, R. Therapeutic implications of immune-endocrine interactions in the critically ill patients. Curr. Drug Targets Immune Endocr. Metabol. Disord., 2004, 4, p. 129-139. Go to original source... Go to PubMed...
    36. Glynne, P., Singer, M., Lord, G. The role of leptin in sepsis. In Year book of intensive care and emergency medicine. Springer-Verlag Berlin : Heidelberg : New York 2004, p. 41-50.
    37. Diez, J. J., Iglesias, P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur. J. Endocrinol., 2003, 148, p. 293-300. Go to original source... Go to PubMed...
    38. Mutlu, G. M., Factor, P. Role of vasopressin in the management of septic shock. Intensive Care Med., 2004, 30, p. 1276-1291. Go to original source... Go to PubMed...
    39. Novák, F., Lubanda, H., Onderková, R., Žák, A. Vazopresin a jeho analoga v léčbě šokových stavů. Čas. Lék. čes., 2004, 143, p. 307-312.
    40. Mullner, M., Urbanek, B., Havel, C., Losert, H., Waechter, F., Gamper, G. Vasopressors for shock. Cochrane Database Syst. Rev., 2004, 3, CD003709. Go to original source... Go to PubMed...
    41. O'Brien, A., Clapp, L., Singer, M. Terlipressin for norepinephrine-resistant septic shock. Lancet, 2002, 359, p. 1209-1210. Go to original source... Go to PubMed...
    42. Rodriguez-Nunez, A., Fernandez-Sanmartin, M., Martinon-Torres, F., Gonzalez-Alonso, N., Martinon-Sanchez, J. M. Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med., 2004, 3, p. 477-480. Go to original source... Go to PubMed...
    43. Matok, I., Leibovitch, L., Vardi, A. et al. Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock. Pediatr. Crit. Care Med., 2004, 2, p. 116-118. Go to original source... Go to PubMed...
    44. de Lemos, J. A., McGuire, D. K., Drazner, M. H. B-type natriuretic peptide in cardiovascular disease. Lancet, 2003, 362, p. 316-322. Go to original source... Go to PubMed...
    45. Bhalla, V., Maisel, A. S., Bhalla, M. A. Evolution of B-type natriuretic peptide in evaluation of intensive care unit shock. Crit. Care Med., 2004, 32, p. 1787-1789. Go to original source... Go to PubMed...
    46. Kruger, S., Graf, J., Merx, M. W. et al. Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am. Heart J., 2004, 147, p. 60-65. Go to original source... Go to PubMed...
    47. Witthaut, R., Busch, C., Fraunberger, P. et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med., 2003, 29, p. 1696-1702. Go to original source... Go to PubMed...
    48. Charpentier, J., Luyt, C. E., Fulla, Y. et al. Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit. Care Med., 2004, 32, p. 660-665. Go to original source... Go to PubMed...
    49. Schwam, E. B-type natriuretic peptide for diagnosis of heart failure in emergency department patients: a critical appraisal. Acad. Emerg. Med., 2004, 11, p. 686-691. Go to original source...
    50. Heyland, D. K., Dhaliwal, R., Drover, J. W., Gramlich, L., Dodek, P. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. J. Parenter. Enteral Nutr., 2003, 27, p. 355-373. Go to original source... Go to PubMed...
    51. Bertolini, G., Iapichino, G., Radrizzani, D. et al. Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med., 2003, 29, p. 834-840. Go to original source... Go to PubMed...
    52. Marik, P. E., Zaloga, G. P. Meta-analysis of parenteral nutrition versus enteral nutrition in patients with acute pancreatitis. BMJ, 2004, 328, p. 1407. Go to original source... Go to PubMed...
    53. Rokyta, R. Jr, Matějovič, M., Kroužecký, A., Novák, I. Enteral nutrition and hepatosplanchnic region in critically ill patients - friends or foes? Physiol. Res., 2003, 52, p. 31-37. Go to original source...
    54. Rokyta, R. Jr, Matějovič, M., Kroužecký, A., Senft, V., Trefil, L., Novák, I. Post-pyloric enteral nutrition in septic patients: effects on hepato-splanchnic hemodynamics and energy status. Intensive Care Med., 2004, 30, p. 714-717. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.